The NIA Imbedded Pragmatic Alzheimer’s Disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory announces a Request for Applications for the Pilot Grants Program Cycle 3B. In this cycle, the IMPACT Collaboratory will fund up to five one-year awards for pilot pragmatic clinical trials (ePCTs) that test non-pharmacological interventions embedded in health care system(s) for people living with Alzheimer’s Disease (AD) and AD-related dementias (ADRD) and their care partners. Under this mechanism, interventions must be linked to the needs of a health care system (HCS). Pilot Studies will be funded for up to $175,000 in direct costs for a maximum of 12-months. Learn more: Pilot Grants Program. An optional informational webinar is scheduled on August 23, 2pm ET: Register here for webinar